… the Netherlands, Feb. 28, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced results for … stable in CF mucus: During the 12th Annual Meeting of the OligonucleotideTherapeuticsSociety (OTS) September 25 – 28, 2016 the company presented a …
… Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that the … October 8 – 10, 2015 and the 11 th Annual Meeting of the OligonucleotideTherapeuticsSociety (OTS) in Leiden, The Netherlands, October 11 – 14, …
… the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … two investor conferences during the month of September. OligonucleotideTherapeuticsSociety During the 12 th Annual Meeting of the …
… the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … the review process. During the 12 th Annual Meeting of the OligonucleotideTherapeuticsSociety (OTS) September 25 – 28, 2016 the company presented a …
… interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on central … Axiomer ® RNA editing technology platform at the OligonucleotideTherapeuticsSociety (OTS) meeting in Bordeaux, France and at the Drug …